Cinctive Capital Management LP Iveric Bio, Inc. Transaction History

Cinctive Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$26.24 - $39.63 $3.93 Million - $5.94 Million	149,923 New	149,923 $5.9 Million
Q2 2022 Aug 15, 2022	SELL	$9.12 - $18.9 $348,383 - $721,980	-38,200 Reduced 46.59%	43,800 $421,000
Q1 2022 May 16, 2022	BUY	$12.15 - $16.83 $328,050 - $454,409	27,000 Added 49.09%	82,000 $1.38 Million
Q4 2021 Feb 14, 2022	BUY	$13.83 - $18.78 $172,556 - $234,318	12,477 Added 29.34%	55,000 $920,000
Q3 2021 Nov 15, 2021	BUY	$7.07 - $17.5 $300,637 - $744,152	42,523 New	42,523 $691,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Cinctive Capital Management LP with notifications on news.